Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: Six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial

Circulation

Volumn 96, Issue 2, 1997, Pages 462-467

  Kastrati, Adnan ^a,c   Schühlen, Helmut ^a   Hausleiter, Jörg ^b   Walter, Hanna ^a   Zitzmann Roth, Eva ^b   Hadamitzky, Martin ^b   Elezi, Shpend ^b   Ulm, Kurt ^a   Dirschinger, Josef ^a   Neumann, Franz Josef ^b   Schömig, Albert ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL CENTER MOTHER TERESA   (Albania)

Author keywords

Anticoagulants; Follow up studies; Platelet aggregation inhibitors; Stents

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; PHENPROCOUMON; TICLOPIDINE;

ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTERY DIAMETER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; STENT; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANGIOPLASTY, BALLOON; ANTICOAGULANTS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PHENPROCOUMON; PLATELET AGGREGATION INHIBITORS; RECURRENCE; STENTS; TICLOPIDINE;

EID: 0342981071     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel MA, for the Benestent Group. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
2. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S, for the Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
3. Ip JH, Fuster V, Israel D, Badimon L, Badimon J, Chesebro JH. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol. 1991;17:77B-88B.
4. Schwartz RS, Holmes DR Jr, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol. 1992;20:1284-1293.
5. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk angioplasty. N Engl J Med. 1994;330:956-961.
6. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M, Weston M, Sigmon K, Anderson KA, Lee KL, Willerson JT, for the EPIC investigators. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet. 1994;343:881-886.
7. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676-1688.
8. Morice MC, Zemour G, Benveniste E, Biron Y, Bourdonnec C, Faivre R, Fajadet J, Gaspard P, Glatt B, Joly P, Labrunie P, Lienhart Y, Marco J, Petiteau PY, Royer T, Valeix B. Intracoronary stenting without coumadin: one month results of a French multicenter study. Cathet Cardiovasc Diagn. 1995;35:1-7.
9. Schömig A, Neumann FJ, Kastrati A, Schühlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth E, Richardt G, Alt E, Schmitt C, Ulm K. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med. 1996;334:1084-1089.
10. Serruys PW, Emanuelsson H, van der Giessen W, Lunn AC, Kimeney F. Macaya C, Rutsch W. Heyndrickx G, Suryapranata H, Legrand V, Goy JJ, Materne P, Bonnier H, Morice MC, Fajadet J, Belardi J, Colombo A, Garcia E, Ruygrok P, de Jaegere P, Morel MA, Heparincoated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II Pilot Study. Circulation. 1996;93:412-422.
11. Schömig A, Kastrati A, Mudra H, Blasini R. Schühlen H, Klauss V, Richardt G, Neumann FJ. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation. 1994;90:2716-2724.
12. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation. 1990;82:1193-1202.
13. Black AJR, Namay DL, Niederman AL, Lembo NJ, Roubin GS, Douglas JS Jr, King SB III. Tear or dissection after coronary angioplasty: morphologic correlates of an ischemic complication. Circulation. 1989;79:1035-1042.
14. Cowley MJ, DiSciascio G, Rehr R, Vetrovec G. Angiographic observations and clinical relevance of coronary thrombus in unstable angina pectoris. Am J Cardiol. 1989;63:108E-113E.
15. Hausleiter J, Nolte CWT, Jost S, Maier-Rudolph W, Stiel GM, Lattermann A, Rudolph W. Progress in quantitative coronary arteriography: improved accuracy for small vessel diameters with 2nd generation QCA systems. Comput Cardiol. 1995:149-152.
16. Fleiss JL. Statistical Methods for Rates and Proportions. New York, NY: John Wiley & Sons: 1981.
17. Kuntz RE, Safian RD, Carrozza JP, Fishman RF, Mansour M, Baim DS. The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting. Circulation. 1992; 86:1827-1835.
18. Sawada Y, Nosaka H, Kimura T, Nobuyoshi M. Initial and six month outcome of Palmaz-Schatz stent implantation: STRESS/Benestent equivalent vs nonequivalent lesions. J Am Coll Cardiol. 1996; 27(suppl A):252A. Abstract.
19. Reiber JHC, Schiemanck LR, van der Zwet PMJ, Goedhart B, Koning G, Lammertsma M, Danse M, Gerbrands JJ, Schalij MJ, Bruschke AVG. State of the art in quantitative coronary arteriography as of 1996. In: Reiber JHC, van der Wall EE, eds. Cardiovascular Imaging. Dordrecht, Netherlands: Kluwer Academic Publishers; 1996:39-56.
20. Califf RM, Fortin DF, Frid DJ, Harlan WR III, Ohman EM, Bengston JR, Nelson CL, Tcheng JE, Mark DB, Slack RS. Restenosis after coronary angioplasty: an overview. J Am Coll Cardiol. 1991;17: 2B-13B.
21. Haude M, Erbel R, Issa H, Meyer J. Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents. J Am Coll Cardiol. 1993;21:26-34.
22. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol. 1995;25:516-520.
23. Popma JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation. 1991;84:1425-1436.
24. Topol EJ, Leya F, Pinkerton CA, Whitlow PL, Höfling B Simonton CA, Masden RR, Serruys PW, Leon MB, Williams DO, King SB III, Mark DB, Isner JM, Holmes DR Jr, Ellis SG, Lee KL, Keeler GP, Berdan LG, Hinohara T, Califf RM. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med. 1993;329:221-227.
25. Taylor RR, Gibbons FA, Cope GD, Cumpston GN, Mews GC, Luke P. Effects of low-dose aspirin on restenosis after coronary angioplasty. Am J Cardiol. 1991;68:874-878.
26. Schwartz L, Bourassa MG, Lespérance J, Aldridge HE, Kazim F, Salvatori VA, Henderson M, Bonan R, David PR. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med. 1988;318:1714-1719.
27. Urban P, Buller N, Fox K, Shapiro L, Bayliss J, Rickards A. Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty. Br Heart J. 1988;60:485-488.
28. Ellis SG, Roubin GS, Wilentz J, Douglas JS Jr, King SB III. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J. 1989;117:777-782.
29. 2-receptor blockade: a randomized, double-blind, placebo-controlled trial: Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT). Circulation. 1991; 84:1568-1580.
30. Serruys PW, Herrman JPR, Simon R, Rutsch W, Bode C, Laarman GJ, van Dijk R, van den Bos AA, Umans VAWM, Fox KAA, Close P, Deckers JW. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. N Engl J Med. 1995; 333:757-763.
31. Schömig A, Kastrati A, Dietz R, Rauch B, Neumann FJ, Katus HH, Busch U. Emergency coronary stenting for dissection during percutaneous transluminal coronary angioplasty: angiographic follow-up after stenting and after repeat angioplasty of the stented segment. J Am Coll Cardiol. 1994;23:1053-1060.
32. Gordon PC, Gibson CM, Cohen DJ, Carrozza JP, Kuntz RE, Baim DS, Mechanisms of restenosis and redilation within coronary stents: quantitative angiographic assessment. J Am Coll Cardiol. 1993;21:1166-1174.
33. Gawaz M, Neumann FJ, Ott I, May A, Schömig A. Platelet activation and coronary stent implantation: effect of antithrombotic therapy. Circulation. 1996;94:279-285.
34. Herbert JM, Tissinier A, Defreyn G, Maffrand JP. Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits. Anerioscler Thromb. 1993;13:1171-1179.
35. Liu MW, Roubin GS, King SB III. Restenosis after coronary angioplasty: potential biologic determinants and role of intimal hyperplasia. Circulation. 1989;79:1374-1387.
36. Harker LA, Bruno JB. Ticlopidine's mechanism of action on human platelets. In: Hass WK, Easton JD, eds. Ticlopidine, Platelets and Vascular Disease. New York, NY: Springer-Verlag; 1993:41-59.
37. Bertrand ME, Allain H, Lablanche JM. Results of a randomized trial of ticlopidine versus placebo for prevention of acute closure and restenosis after coronary angioplasty: the TACT Study. Circulation. 1990;82(suppl III):III-190. Abstract.
38. Handin RI. Platelets and coronary artery disease. N Engl J Med. 1996;334:1126-1127.